XXII vs CANN
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 15, 2026
XXII
43.1
AI Score
VS
XXII Wins
CANN
0
AI Score
Investment Advisor Scores
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | XXII | CANN | Winner |
|---|---|---|---|
| Revenue | 20.36M | 10.69M | XXII |
| Net Income | -10.61M | -3.03M | CANN |
| Net Margin | -52.1% | -28.4% | CANN |
| Operating Income | -9.86M | -535,185 | CANN |
| ROE | -305.5% | 115.6% | CANN |
| ROA | -40.5% | -14.3% | CANN |
| Total Assets | 26.18M | 21.16M | XXII |
| Cash | 5.34M | 245,367 | XXII |
| Debt/Equity | 2.02 | -5.78 | CANN |
| Current Ratio | 1.09 | 0.16 | XXII |
| Free Cash Flow | -10.09M | -527,570 | CANN |
Frequently Asked Questions
Based on our detailed analysis, XXII is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.